359 related articles for article (PubMed ID: 25986047)
1. Molecular markers of anti-malarial drug resistance in southwest Ethiopia over time: regional surveillance from 2006 to 2013.
Heuchert A; Abduselam N; Zeynudin A; Eshetu T; Löscher T; Wieser A; Pritsch M; Berens-Riha N
Malar J; 2015 May; 14():208. PubMed ID: 25986047
[TBL] [Abstract][Full Text] [Related]
2. Return of chloroquine-sensitive Plasmodium falciparum parasites and emergence of chloroquine-resistant Plasmodium vivax in Ethiopia.
Mekonnen SK; Aseffa A; Berhe N; Teklehaymanot T; Clouse RM; Gebru T; Medhin G; Velavan TP
Malar J; 2014 Jun; 13():244. PubMed ID: 24964730
[TBL] [Abstract][Full Text] [Related]
3. Detection of high levels of mutations involved in anti-malarial drug resistance in Plasmodium falciparum and Plasmodium vivax at a rural hospital in southern Ethiopia.
Mula P; Fernández-Martínez A; de Lucio A; Ramos JM; Reyes F; González V; Benito A; Berzosa P
Malar J; 2011 Aug; 10():214. PubMed ID: 21810256
[TBL] [Abstract][Full Text] [Related]
4. High prevalence of drug-resistance mutations in Plasmodium falciparum and Plasmodium vivax in southern Ethiopia.
Schunk M; Kumma WP; Miranda IB; Osman ME; Roewer S; Alano A; Löscher T; Bienzle U; Mockenhaupt FP
Malar J; 2006 Jul; 5():54. PubMed ID: 16817953
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of Plasmodium falciparum Pfcrt and Pfmdr1 alleles in settings with different levels of Plasmodium vivax co-endemicity in Ethiopia.
Hailemeskel E; Menberu T; Shumie G; Behaksra S; Chali W; Keffale M; Belachew M; Shitaye G; Mohammed H; Abebe D; Ashine T; Drakeley C; Mamo H; Petros B; Bousema T; Tadesse FG; Gadisa E
Int J Parasitol Drugs Drug Resist; 2019 Dec; 11():8-12. PubMed ID: 31539706
[TBL] [Abstract][Full Text] [Related]
6. Transmission dynamics of co-endemic Plasmodium vivax and P. falciparum in Ethiopia and prevalence of antimalarial resistant genotypes.
Lo E; Hemming-Schroeder E; Yewhalaw D; Nguyen J; Kebede E; Zemene E; Getachew S; Tushune K; Zhong D; Zhou G; Petros B; Yan G
PLoS Negl Trop Dis; 2017 Jul; 11(7):e0005806. PubMed ID: 28746333
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of molecular markers of anti-malarial drug resistance in Plasmodium vivax and Plasmodium falciparum in two districts of Nepal.
Ranjitkar S; Schousboe ML; Thomsen TT; Adhikari M; Kapel CM; Bygbjerg IC; Alifrangis M
Malar J; 2011 Apr; 10():75. PubMed ID: 21457533
[TBL] [Abstract][Full Text] [Related]
8. Increased prevalence of the Plasmodium falciparum Pfmdr1 86N genotype among field isolates from Franceville, Gabon after replacement of chloroquine by artemether-lumefantrine and artesunate-mefloquine.
Lekana-Douki JB; Dinzouna Boutamba SD; Zatra R; Zang Edou SE; Ekomy H; Bisvigou U; Toure-Ndouo FS
Infect Genet Evol; 2011 Mar; 11(2):512-7. PubMed ID: 21251998
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated malaria in Papua New Guinea.
Tavul L; Hetzel MW; Teliki A; Walsh D; Kiniboro B; Rare L; Pulford J; Siba PM; Karl S; Makita L; Robinson L; Kattenberg JH; Laman M; Oswyn G; Mueller I
Malar J; 2018 Oct; 17(1):350. PubMed ID: 30290825
[TBL] [Abstract][Full Text] [Related]
10. Different mutation patterns of Plasmodium falciparum among patients in Jimma University Hospital, Ethiopia.
Eshetu T; Berens-Riha N; Fekadu S; Tadesse Z; Gürkov R; Hölscher M; Löscher T; Miranda IB
Malar J; 2010 Aug; 9():226. PubMed ID: 20691106
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility of Plasmodium falciparum to artemisinins and Plasmodium vivax to chloroquine in Phuoc Chien Commune, Ninh Thuan Province, south-central Vietnam.
Phong NC; Chavchich M; Quang HH; San NN; Birrell GW; Chuang I; Martin NJ; Manh ND; Edstein MD
Malar J; 2019 Jan; 18(1):10. PubMed ID: 30654808
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and patterns of antifolate and chloroquine drug resistance markers in Plasmodium vivax across Pakistan.
Khattak AA; Venkatesan M; Khatoon L; Ouattara A; Kenefic LJ; Nadeem MF; Nighat F; Malik SA; Plowe CV
Malar J; 2013 Sep; 12():310. PubMed ID: 24007534
[TBL] [Abstract][Full Text] [Related]
13. Active case detection, treatment of falciparum malaria with combined chloroquine and sulphadoxine/pyrimethamine and vivax malaria with chloroquine and molecular markers of anti-malarial resistance in the Republic of Vanuatu.
Kinzer MH; Chand K; Basri H; Lederman ER; Susanti AI; Elyazar I; Taleo G; Rogers WO; Bangs MJ; Maguire JD
Malar J; 2010 Apr; 9():89. PubMed ID: 20370920
[TBL] [Abstract][Full Text] [Related]
14. Surveillance of artemether-lumefantrine associated Plasmodium falciparum multidrug resistance protein-1 gene polymorphisms in Tanzania.
Kavishe RA; Paulo P; Kaaya RD; Kalinga A; van Zwetselaar M; Chilongola J; Roper C; Alifrangis M
Malar J; 2014 Jul; 13():264. PubMed ID: 25007802
[TBL] [Abstract][Full Text] [Related]
15. Temporal trends of molecular markers associated with artemether-lumefantrine tolerance/resistance in Bagamoyo district, Tanzania.
Malmberg M; Ngasala B; Ferreira PE; Larsson E; Jovel I; Hjalmarsson A; Petzold M; Premji Z; Gil JP; Björkman A; Mårtensson A
Malar J; 2013 Mar; 12():103. PubMed ID: 23506218
[TBL] [Abstract][Full Text] [Related]
16. K13-Propeller Polymorphisms in Plasmodium falciparum Isolates from Patients in Mayotte in 2013 and 2014.
Torrentino-Madamet M; Collet L; Lepère JF; Benoit N; Amalvict R; Ménard D; Pradines B
Antimicrob Agents Chemother; 2015 Dec; 59(12):7878-81. PubMed ID: 26416865
[TBL] [Abstract][Full Text] [Related]
17. A Unique Plasmodium falciparum K13 Gene Mutation in Northwest Ethiopia.
Bayih AG; Getnet G; Alemu A; Getie S; Mohon AN; Pillai DR
Am J Trop Med Hyg; 2016 Jan; 94(1):132-5. PubMed ID: 26483118
[TBL] [Abstract][Full Text] [Related]
18. Microscopic and molecular evidence of the presence of asymptomatic Plasmodium falciparum and Plasmodium vivax infections in an area with low, seasonal and unstable malaria transmission in Ethiopia.
Golassa L; Baliraine FN; Enweji N; Erko B; Swedberg G; Aseffa A
BMC Infect Dis; 2015 Aug; 15():310. PubMed ID: 26242405
[TBL] [Abstract][Full Text] [Related]
19. Absence of in vivo selection for K13 mutations after artemether-lumefantrine treatment in Uganda.
Balikagala B; Mita T; Ikeda M; Sakurai M; Yatsushiro S; Takahashi N; Tachibana SI; Auma M; Ntege EH; Ito D; Takashima E; Palacpac NM; Egwang TG; Onen JO; Kataoka M; Kimura E; Horii T; Tsuboi T
Malar J; 2017 Jan; 16(1):23. PubMed ID: 28068997
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic efficacy of artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Enfranze, north-west Ethiopia.
Getnet G; Fola AA; Alemu A; Getie S; Fuehrer HP; Noedl H
Malar J; 2015 Jun; 14():258. PubMed ID: 26105035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
